Processing

Please wait...

Settings

Settings

Goto Application

1. WO2016039367 - NOVEL PHARMACEUTICAL COMPOSITION FOR URINARY INCONTINENCE PREVENTION AND/OR TREATMENT

Publication Number WO/2016/039367
Publication Date 17.03.2016
International Application No. PCT/JP2015/075567
International Filing Date 09.09.2015
IPC
A61K 31/506 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
506not condensed and containing further heterocyclic rings
A61P 13/02 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13Drugs for disorders of the urinary system
02of urine or of the urinary tract, e.g. urine acidifiers
C07D 401/14 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
401Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
14containing three or more hetero rings
CPC
A61K 31/136
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
13Amines
135having aromatic rings ; , e.g. ketamine, nortriptyline
136having the amino group directly attached to the aromatic ring, e.g. benzeneamine
A61K 31/40
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
A61K 31/506
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two ; or more; nitrogen atoms as the only ring heteroatoms, e.g. piperazine ; or tetrazines
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
506not condensed and containing further heterocyclic rings
A61P 13/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13Drugs for disorders of the urinary system
02of urine or of the urinary tract, e.g. urine acidifiers
A61P 21/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
21Drugs for disorders of the muscular or neuromuscular system
A61P 7/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
7Drugs for disorders of the blood or the extracellular fluid
12Antidiuretics, e.g. drugs for diabetes insipidus
Applicants
  • アステラス製薬株式会社 ASTELLAS PHARMA INC. [JP]/[JP]
  • サイトキネティクス・インコーポレーテッド CYTOKINETICS INCORPORATED [US]/[US]
Inventors
  • 森 しのぶ MORI Shinobu
  • 加治原 佑介 KAJIHARA Yusuke
  • 稲村 広子 INAMURA Hiroko
  • 平田 拓也 HIRATA Takuya
Agents
  • 平木 祐輔 HIRAKI Yusuke
Priority Data
2014-18343409.09.2014JP
Publication Language Japanese (ja)
Filing Language Japanese (JA)
Designated States
Title
(EN) NOVEL PHARMACEUTICAL COMPOSITION FOR URINARY INCONTINENCE PREVENTION AND/OR TREATMENT
(FR) NOUVELLE COMPOSITION PHARMACEUTIQUE POUR LA PRÉVENTION ET/OU LE TRAITEMENT DE L'INCONTINENCE URINAIRE
(JA) 尿失禁予防用及び/又は治療用新規医薬組成物
Abstract
(EN) The present invention addresses the problem of providing a novel pharmaceutical composition for urinary incontinence prevention and/or treatment, said pharmaceutical composition being different from conventional drugs. The present invention provides a urinary incontinence preventive agent and/or therapeutic agent that have, as an active ingredient, 1-[2({[trans-3-fluoro-1-(3-fluoropyridine-2-yl)cyclobutyl]methyl}amino)pyrimidine-5-yl]-1H-pyrrole-3-carboxamide or a salt thereof.
(FR) La présente invention aborde le problème de fourniture d'une nouvelle composition pharmaceutique pour la prévention et/ou le traitement de l'incontinence urinaire, ladite composition pharmaceutique étant différente des médicaments classiques. La présente invention concerne un agent de prévention et/ou un agent thérapeutique de l'incontinence urinaire qui ont, en tant que constituant actif, du 1-[2({[trans-3-fluoro-1-(3-fluoropyridine-2-yl)cyclobutyl]méthyl}amino)pyrimidine-5-yl]-1H-pyrrole-3-carboxamide ou un sel de ce dernier.
(JA) 本発明の課題は、従来の薬剤とは異なる、新規な尿失禁予防用及び/又は治療用医薬組成物を提供することである。本発明は、1-[2-({[トランス-3-フルオロ-1-(3-フルオロピリジン-2-イル)シクロブチル]メチル}アミノ)ピリミジン-5-イル]-1H-ピロール-3-カルボキサミド又はその塩を有効成分とする、尿失禁予防剤及び/又は治療剤を提供する。
Related patent documents
CN201580048573.4This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
Latest bibliographic data on file with the International Bureau